Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

NCT04942730 is registered in ClinicalTrials.gov with St. Petersburg State Pavlov Medical University as lead sponsor.

NCT NCT04942730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
Lead sponsor
St. Petersburg State Pavlov Medical University
Phase
Phase 2
Overall status
Completed
Start date
January 21, 2021
Completion date
April 30, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biphenotypic acute leukemia, leukemia, acute lymphoblastic, lymphoblastic lymphoma, myelodysplastic syndromes, myeloid leukemia, acute, myeloproliferative neoplasm